BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy
January 30, 2024 08:30 ET
|
BioSig Technologies, Inc.
Cost Savings Targeted to Reduce Cash Burn by 50% Core Strategy Shifts to Business Development and Distribution Partnerships Westport, CT, Jan. 30, 2024 (GLOBE NEWSWIRE) -- BioSig...
Cardiac Mapping Market Projected to Reach USD 6.98 Billion by 2034, Driven by Technological Advances and Growing Cardiac Disease Prevalence
January 30, 2024 06:05 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Cardiac Mapping Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global landscape...
BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024
December 06, 2023 14:20 ET
|
BioSig Technologies, Inc.
Westport, CT, Dec. 06, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients
November 28, 2023 08:42 ET
|
Stereotaxis, Inc.
Baptist Health Lexington has become one of the first in the world to provide the latest in robotic technology to treat arrhythmias
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 13, 2023 16:30 ET
|
BioSig Technologies, Inc.
Westport, CT, Nov. 13, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company committed to delivering unprecedented accuracy and...
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 09, 2023 08:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Westport, CT, Nov. 9, 2023 -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company committed to...
BioSig Appoints Global MedTech Leader Fred Hrkac as New Executive VP
November 07, 2023 08:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Westport, CT, November 7, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company...
Electrophysiology Devices Global Strategic Business Report: Players Include CardioFocus, Medtronic, MicroPort Scientific and Nihon Kohden
November 07, 2023 07:23 ET
|
Research and Markets
Dublin, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The "Electrophysiology Devices: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Global Electrophysiology Catheters Market 2023 - 2027: Players Include Medtronic, Merit Medical Systems, MicroPort Scientific and Millar
November 03, 2023 06:13 ET
|
Research and Markets
Dublin, Nov. 03, 2023 (GLOBE NEWSWIRE) -- The "Global Electrophysiology Catheters Market 2023-2027" report has been added to ResearchAndMarkets.com's offering.The electrophysiology catheters market...
BioSig’s New PURE EP™ Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac Care
November 02, 2023 08:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Nov. 02, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company committed to delivering unprecedented accuracy and...